Is Cytarabine Useful in the Treatment of Acute Promyelocytic Leukemia? Results of a Randomized Trial From the European Acute Promyelocytic Leukemia Group
Lionel Adès(Délégation Paris 7), Pierre Fenaux(Saint Louis University Hospital), Françoise Rigal‐Huguet(Hôpital Purpan), Sandrine Meyer‐Monard(University Hospital of Basel), Stéphane de Botton(Université Paris-Saclay), Christine Chomienne(Inserm), Éric Deconinck(European Union), Augustin Ferrant(Cliniques Universitaires Saint-Luc), Anne Vekhoff(Hôtel-Dieu de Paris), Frédéric Maloisel(European Union), Sylvie Chevret(Saint Louis University Hospital), Emmanuel Raffoux(Inserm), Nathalie Fegueux(European Union), Xavier Thomas(Hôpital Lyon Sud), T. Lamy(Centre Hospitalier Universitaire de Rennes), Laurent Degos(Inserm), Anne Marie Stoppa, Hervé Dombret(University of London Institute in Paris), Agnès Guerci(Centre Hospitalier Régional et Universitaire de Nancy), Arnaud Pigneux(Centre Hospitalier Universitaire de Bordeaux)
Cited by 166
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k